Skip to main content

Table 2 Clinical presentation and complications of immunosuppressed patients with influenza infections

From: Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015–2020 influenza seasons

 

All types (n = 111)

Malignancies (n = 71)

HSCT (n = 26)

Autoimmune disorders (n = 10)

Fever (%)

103/111 (92.8)

69/71 (97.2)

22/26 (84.6)

8/10 (80.0)

Sore throat (%)

16/72 (22.2)

11/50 (22.0)

2/14 (14.3)

2/7 (28.6)

Rhinorrhoea (%)

20/73 (27.4)

8/49 (16.3)

6/16 (37.5)

4/7 (57.1)

Cough (%)

44/87 (50.6)

22/54 (40.7)

16/22 (72.7)

5/9 (55.6)

Headache (%)

16/71 (22.5)

8/48 (16.7)

2/13 (15.4)

5/9 (55.6)

Muscle soreness (%)

22/68 (32.4)

14/49 (28.6)

3/13 (23.1)

3/5 (60.0)

Dyspnoea (%)

13/76 (17.1)

4/51 (7.8)

8/19 (42.1)

0/5 (0.0)

Gastrointestinal symptoms (%)

12/78 (15.4)

6/52 (11.5)

6/19 (31.6)

0/5 (0.0)

Altered mental status (%)

6/95 (6.3)

2/58 (3.4)

3/24 (12.5)

0/10 (0.0)

Symptom onset, hours (range)

24.0 (2.0–456.0)

24.0 (6.0–312.0)

60.0 (24.0–456.0)

24.0 (2.0–96.0)

Coinfection with other pathogens (%)

21/111 (18.9)

10/71 (14.1)

11/26 (42.3)

0/10 (0.0)

Complications (%)

45/111 (40.5)

22/71 (31.0)

17/26 (65.4)

4/10 (40.0)

Pneumonia on chest radiograph or CT scan (%)

42/98 (42.9)

21/61 (34.4)

16/24 (66.7)

4/9 (44.4)

Acute respiratory distress syndrome (%)

10/111 (9.0)

3/71 (4.2)

7/26 (26.9)

0/10 (0.0)

Shock (%)

7/111 (6.3)

2/71 (2.8)

3/26 (11.5)

0/10 (0.0)

Acute kidney injury (%)

4/111 (3.6)

0/71 (0.0)

2/26 (7.7)

1/10 (10.0)

Viral encephalitis (%)

1/111 (0.9)

0/71 (0.0)

1/26 (3.8)

0/10 (0.0)

Admission to the ICU (%)

16/111 (14.4)

8/71 (11.3)

7/26 (26.9)

0/10 (0.0)

Mechanical ventilation (%)

9/111 (8.1)

2/71 (2.8)

7/26 (26.9)

0/10 (0.0)

Virus detection turning negative, days (range)*

3.0 (1.0–11.0)

3.0 (1.0–11.0)

3.0 (1.0–9.0)

7.0 (2.0–9.0)

Number of hospitalization days (range)

15.0 (1.0–130.0)

12.0 (1.0–65.0)

44.0 (1.0–130.0)

10.5 (4.0–56.0)

Death (%)

11/111 (9.9)

4/71 (5.6)

7/26 (26.9)

0/10 (0.0)

  1. *Data are available only for 41 patients; HSCT, haematopoietic stem cell transplantation; ICU, intensive care unit